CT SB00028 | 2023 | General Assembly
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 12 2023 - 25% progression, died in committee
Action: 2023-01-12 - Referred to Joint Committee on Insurance and Real Estate
Pending: Joint Insurance and Real Estate Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 12 2023 - 25% progression, died in committee
Action: 2023-01-12 - Referred to Joint Committee on Insurance and Real Estate
Pending: Joint Insurance and Real Estate Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To (1) prohibit certain health carriers from requiring the use of step therapy for drugs prescribed to treat behavioral health conditions or chronic, disabling or life-threatening conditions or diseases; (2) redefine "clinical peer" for the purposes of adverse determination and utilization reviews; (3) require health carriers to bear the burden of proving that certain health care services under adverse determination or utilization review are not medically necessary; and (4) require health carriers to provide certain clinical peers with authority to reverse initial adverse determinations.
Title
An Act Concerning Step Therapy, Adverse Determination And Utilization Reviews.
Sponsors
Sen. Saud Anwar [D] |
History
Date | Chamber | Action |
---|---|---|
2023-01-12 | Senate | Referred to Joint Committee on Insurance and Real Estate |
Connecticut State Sources
Type | Source |
---|---|
Summary | https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB00028&which_year=2023 |
Text | https://www.cga.ct.gov/2023/TOB/S/PDF/2023SB-00028-R00-SB.PDF |